Complaints Associated With Use of Pre-Filled Pen B With Type 2 Diabetics on Twice-Daily Insulin

Completed · Phase 3

Conditions studied: Type 2 Diabetes Mellitus

In brief

Trial of new insulin injection pen called Pre-filled Pen B by type 2 diabetics in take home situations. Patients must use insulin lispro injection \[rDNA origin\] Low Mix twice daily during the trial.

Key facts

Study ID
NCT00231725
Run by
Eli Lilly and Company
People needed
370
Starts
2005-09-01
Expected to finish
2006-04-01
Last updated by the study team
2007-06-27

Who can join

Age: 25 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.